Literature DB >> 1972209

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

J A Garson1, R S Tedder, M Briggs, P Tuke, J A Glazebrook, A Trute, D Parker, J A Barbara, M Contreras, S Aloysius.   

Abstract

Of 1100 blood donations tested during a prospective study of post-transfusion non-A, non-B hepatitis (NANBH), 6 (0.55%) were repeatedly reactive in a commercial assay for antibodies to the C100 protein of hepatitis C virus. Only 1 of the 6 donations (17%) transmitted NANBH to a recipient. Hepatitis C virus RNA sequences were detected in the serum of the transmitting donor by an assay which used the polymerase chain reaction (PCR) and non-radioisotopic detection. No such sequences were detected in the other 5 donors positive for anti-C100. Stored serum samples from blood donors who had been involved in three episodes of post-transfusion NANBH in 1981 also contained hepatitis C viral sequences. Although the PCR assay in its present form is not suitable for mass donor screening, the presence of hepatitis C viral sequences detected by PCR in blood donations seems a better predictor of infectivity than the presence of anti-C100 alone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972209     DOI: 10.1016/0140-6736(90)91446-h

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  77 in total

1.  Approaches of the diagnosis of hepatitis viruses.

Authors:  G J Kotwal
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

Review 2.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus.

Authors:  J T Wang; T H Wang; J C Sheu; S M Lin; J T Lin; D S Chen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

4.  Infection of Chang cells with hepatitis C virus using hepatic biopsy specimens from patients with chronic hepatitis (type C).

Authors:  T Ozeki; K Hikiji; K Funakoshi; M Tsutsumi; A Yoshida
Journal:  Int J Exp Pathol       Date:  1992-02       Impact factor: 1.925

5.  Sexual transmission of hepatitis C virus.

Authors:  P P Mortimer
Journal:  BMJ       Date:  1990-12-08

6.  Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens.

Authors:  C Ishida; K Matsumoto; K Fukada; K Matsushita; H Shiraki; Y Maeda
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

7.  Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients.

Authors:  F M Fink; S Höcker-Schulz; W Mor; E Puchhammer-Stöckl; H Hofmann; A Zoubek; J Pawlowsky; P Höcker; H Gadner
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

8.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

9.  Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.

Authors:  A Nishizono; M Hiraga; K Mifune; H Terao; T Fujioka; M Nasu; T Goto; J Misumi; M Moriyama; Y Arakawa
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection.

Authors:  J M Durand; E Cretel; G Kaplanski; P Lefevre; F Retornaz; J Soubeyrand
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.